Advertisement
UK markets close in 5 hours 1 minute
  • FTSE 100

    8,129.34
    -17.52 (-0.22%)
     
  • FTSE 250

    20,115.46
    -4.90 (-0.02%)
     
  • AIM

    775.33
    -0.71 (-0.09%)
     
  • GBP/EUR

    1.1828
    -0.0017 (-0.15%)
     
  • GBP/USD

    1.2662
    -0.0024 (-0.19%)
     
  • Bitcoin GBP

    51,827.60
    -580.19 (-1.11%)
     
  • CMC Crypto 200

    1,358.41
    -29.75 (-2.14%)
     
  • S&P 500

    5,431.60
    -2.14 (-0.04%)
     
  • DOW

    38,589.16
    -57.94 (-0.15%)
     
  • CRUDE OIL

    78.26
    -0.19 (-0.24%)
     
  • GOLD FUTURES

    2,336.90
    -12.20 (-0.52%)
     
  • NIKKEI 225

    38,102.44
    -712.12 (-1.83%)
     
  • HANG SENG

    17,936.12
    -5.66 (-0.03%)
     
  • DAX

    17,997.14
    -4.88 (-0.03%)
     
  • CAC 40

    7,495.84
    -7.43 (-0.10%)
     

Global Single-cell Analysis Market Analysis Report 2024-2030, by Product (Consumables, Instruments), Application (Cancer, Stem Cell), Workflow (Downstream Analysis, Data Analysis), End-use and Region

Company Logo
Company Logo

Dublin, June 11, 2024 (GLOBE NEWSWIRE) -- The "Global Single-cell Analysis Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Application (Cancer, Stem Cell), Workflow (Downstream Analysis, Data Analysis), End-use, Region, and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.com's offering.

The global single-cell analysis market size was estimated at USD 13.69 billion in 2030 and is projected to grow at a CAGR of 18.7% from 2024 to 2030.

Technology advances, expanding applications in cancer research, and higher government funding for cell-based research are the main drivers of the market. In addition, the market is advancing as a result of the COVID-19 pandemic. For instance, in January 2021, according to the American Journal of Physiology, variations in the peripheral blood mononuclear cellular profiles of COVID-19-infected patients were examined by using single-cell analysis (SEA) through mass cytometry, which supplemented the industry growth.

Government agencies around the world have increased funding for vaccine development and production in response to the ongoing pandemic's economic and social costs, which has increased the use of SEA tools for COVID-19 research. In order to develop better prognostic and diagnostic indicators and establish suitable therapeutic approaches for people with serious disease presentation, it is essential to know the host immune response throughout pathogenicity. Therefore, the market is positively impacted by COVID-19 because single-cell analysis helps in the assessment of peripheral immune function in the disease and makes new contributions to the study of the disease's pathophysiology and treatment possibilities.

Single-cell technology aids in the molecular level examination of pathways and processes as well as the assessment of cellular heterogeneity. This technology is developing rapidly with uses in oncology, immunology, and other fields. Further, the development of sophisticated tools that make transcriptomic and proteomic processes simpler is boosting the use of SEA methods. Researchers are now able to comprehensively examine previously unstudied uncommon cell types owing to developments in scRNA sequencing (scRNAseq). The application of single-cell genomic/transcriptomic analysis in the biomedical area has been greatly expanded by the development of microfluidics technology. Furthermore, cell dissociation and tissue digestion have been adapted for a large range of microfluidic devices, which have increased the adoption of SEA technology and further boosted industry growth.

The rising investment flow in R&D in this space is reflected in the rising number of research publications. For instance, in April 2020, A USD 2 million funding round was headed by the venture capital firm i&i Biotech Fund for Sampling Human, a young life science technology startup that has created a diagnostic platform that uses genetically modified cells to examine other cells in their environment (i&i Bio). Further, R&D and business growth will all be advanced by the investment. Moreover, these expenditures indicate a better growth opportunity for this market because R&D efforts serve as the foundation for innovation. Additionally, scientists are analyzing geographic variability in gene expression profiles at the single-cell level, which is expected to increase the demand for consumables and equipment for analysis, thus propelling the industry's growth.

Single-cell Analysis Market Report Highlights

  • By product, the consumables segment held the largest revenue share in 2021. The segment is anticipated to be driven by the extensive use of consumables in genetic research, exosome analysis, and RNA and DNA isolation

  • Based on application, the cancer segment captured the largest revenue share in 2022. The segment is being driven by single-cell analysis, which has shown to be successful for earlier cancer diagnoses. These techniques make it simple to determine cell kinds, mutation rates, and growth settings

  • In terms of workflow, the single cell isolation and library preparation segment held the largest revenue share in 2022. Increasing research using single-cell analysis is anticipated to boost the revenue growth

  • Based on end-user, the academic and research laboratories segment held the largest revenue share in 2022. The widespread use of different SEA techniques in research settings has been influenced by a sizeable number of ongoing research projects at academic institutions that use SEA assays

  • North America held the largest revenue share in 2022. This is mostly attributed to the occurrence of significant market participants and rising R&D spending and federal assistance

  • Asia Pacific is expected to grow at the highest rate over the forecast period owing to factors such as the increasing prevalence of target diseases, growing aging population, and rising single cell technology adoption

ADVERTISEMENT

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Single-cell Analysis Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expanding Application Scope
3.2.1.1.1. Disease Diagnosis
3.2.1.1.2. Drug Discovery & Development
3.2.1.2. Lucrative Growth of Sequencing Technology
3.2.1.3. Technological Innovations in Single-cell Analysis and Cell Isolation
3.2.1.4. Rising Incidence of Cancer
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost of Instruments
3.2.2.2. Higher Penetration of Conventional Mode of Gene & Cell Analysis
3.3. Single-cell Analysis Market Analysis Tools

Chapter 4. Single-cell Analysis Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Single-cell Analysis Market Product Movement Analysis
4.3. Global Single-cell Analysis Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Consumables
4.4.2. Reagents
4.4.3. Assay Kits
4.5. Instrument
4.5.2. Microscope
4.5.3. Hemocytometers
4.5.4. Flow Cytometers
4.5.5. Next Generation Sequencing Systems
4.5.6. PCR
4.5.7. High Content Screening Systems
4.5.8. Cell Microarrays
4.5.9. Single Live Cell Imaging
4.5.10. Automated Cell Counters

Chapter 5. Single-cell Analysis Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Single-cell Analysis Market Application Movement Analysis
5.3. Global Single-cell Analysis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Cancer
5.5. Immunology
5.6. Neurology
5.7. Stem Cell
5.8. Non-invasive Prenatal Diagnosis
5.9. In-vitro Fertilisation
5.10. Heart Cells
5.11. Skeletal and Muscle Cells
5.12. Others

Chapter 6. Single-cell Analysis Market: Workflow Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Single-cell Analysis Market Workflow Movement Analysis
6.3. Global Single-cell Analysis Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
6.4. Single Cell Isolation & Library Preparation
6.5. Downstream Analysis
6.6. Data Analysis

Chapter 7. Single-cell Analysis Market: End-Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Single-cell Analysis Market End-Use Movement Analysis
7.3. Global Single-cell Analysis Market Size & Trend Analysis, by End-Use, 2018 to 2030 (USD Million)
7.4. Academic and Research Laboratories
7.5. Biotechnology and Pharmaceutical Companies
7.6. Hospitals and Diagnostic Laboratories
7.7. Others

Chapter 8. Single-cell Analysis Market: Regional Estimates & Trend Analysis by Product, Application, Workflow & End-use.
8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2024 & 2030
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:

Chapter 9. Competitive Landscape
9.1. Financial Performance
9.2. Participant Categorization
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing

  • Thermo Fisher Scientific, Inc

  • QIAGEN NV

  • Bio-Rad Laboratories, Inc.

  • Illumina, Inc.

  • Merck KGaA

  • Becton, Dickinson & Company (BD)

  • Fluidigm Corporation (Standard BioTools Inc.)

  • 10x Genomics, Inc.

  • BGI

  • Novogene Co, Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/j9iey8

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900